Accordingly, quantitative methylation-specific PCR-based analysis, reported by Brait et al. (2017) [35], demonstrated that 94% of tumour biopsies but 0% of matching serum samples of patients with early stage PCa showed GSTP1 DNA hypermethylation. The gene discussed is GSTP1; the disease is posterior cortical atrophy.